Monrovia [Liberia], December 12 (ANI): India and Liberia on Thursday signed a Memorandum of Understanding (MoU) to strengthen cooperation in the field of pharmacopoeia, a step toward regulatory alignment and improved access to safe and affordable medicines.
The agreement, the Ministry of Health said, aims to promote shared quality standards between the two countries. It was signed by India’s Ambassador to Liberia, Manoj Bihari Verma, and Liberia’s Health Minister, Dr. Louise M. Kpoto.
The Ministry of Health posted on X that the MoU will support improved access to safe and affordable medicines and boost India-Liberia partnership. The Embassy of India in Monrovia said the agreement will allow Liberia to adopt the Indian Pharmacopoeia as a reference for medicine quality standards, strengthening regulatory collaboration and enhancing availability of safe, effective and affordable medicines in Liberia.
The Ministry of AYUSH notes that pharmacopoeias are official compendia of quality standards for drugs imported, manufactured, stocked or distributed in India. Pharmacopoeial monographs set standards to ensure identity, purity and strength through botanical identification, physico-chemical parameters and assays for elements, functional groups or marker compounds. They also specify analytical techniques such as High Performance Thin-Layer Chromatography (HPTLC), High Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), UV-Visible Spectrophotometry, Atomic Absorption Spectroscopy (AAS) and Inductively Coupled Plasma Atomic Emission Spectroscopy (ICP-AES) / Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for detailed profiling. Limits for heavy/toxic metals, pesticide residues, aflatoxins and microbial contamination are also prescribed. (ANI)
(This content is sourced from a syndicated feed and is published as received. The Tribune assumes no responsibility or liability for its accuracy, completeness, or content.)
